Lucid Diagnostics share price logo

Lucid Diagnostics

NASDAQ: LUCD

$0.42

+0.02

(+4.90%)

as on

Lucid Diagnostics Stock Performance

as on November 10, 2026 at 2:16 pm IST

  • Day's Low

    Day's High

    $0.40
    $0.43
    downward going graph

    4.19%

    Downside

    2.99%

    Upside

    downward going graph

  • 52 Week's Low

    52 Week's High

    $0.30
    $1.63
    downward going graph

    27.43%

    Downside

    290.25%

    Upside

    downward going graph

Lucid Diagnostics share price movements today

Previous Close
$0.40
Open
$0.40
Volume
1.4M
Market Cap
$76.0M
Day's Low - High
$0.40 - $0.43
52 Week Low - High
$0.30 - $1.63

Lucid Diagnostics Historical Returns

1 Month Return
-34.56 %
3 Month Return
-56.56 %
1 Year Return
-60.24 %
3 Year Return
-64.01 %
5 Year Return
-95.63 %

Lucid Diagnostics Stock Fundamentals & Key Indicators

Check Lucid Diagnostics market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$76.0M

EPS (TTM)

-0.4661

Dividend Yield

0.00%

Quarterly Earnings Growth YOY

0.00%

PE Ratio (TTM)

-0.85

Industry PE ratio

-4.21

PEG Ratio

-0.01

EBITDA

-51.4M

Revenue (TTM)

5.4M

Profit Margin

-25.79%

Return On Equity TTM

-404.34%

Lucid Diagnostics vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Lucid Diagnostics with its industry peers.

Company
Analyst View
Market Cap
5 Years Return %PE RatioProfit Margin %Dividend Yield %
Lucid Diagnostics image
Lucid Diagnostics
StrongBuy$76.0M-95.63%-0.85-25.79%0.00%
Edwards Lifesciences image
Edwards Lifesciences
StrongBuy$58.7B-11.84%57.7178.13%0.00%
Medtronic image
Medtronic
Buy$130.2B-16.03%24.8966.69%2.81%
Stryker image
Stryker
StrongBuy$124.1B20.17%34.4765.52%1.08%
Abbott Laboratories image
Abbott Laboratories
StrongBuy$190.4B-13.54%40.7157.12%2.29%
See all

Stock Returns calculator for Lucid Diagnostics Stock including INR - Dollar returns

The Lucid Diagnostics stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Impact: The bonus return you make when the US Dollar rises against the Rupee; calculated on the full amount you walk away with, not just what you invested in.

Investment Value

₹1,00,000

  • 1Y

  • 3Y

  • 5Y

Lucid Diagnostics investment value today

Current value as on today

₹42,102

Returns

-₹57,898

(-57.9%)

Returns from Lucid Diagnostics Stock

-₹60,238 (-60.24%)

Dollar Impact

₹2,340 (+2.34%)

Analyst Recommendation on Lucid Diagnostics Stock

Based on 3 analysts

BUY

100.00%

Buy

0.00%

Hold

0.00%

Sell

Based on 3 analysts, 100% of analysts recommend a 'BUY' rating for Lucid Diagnostics. Average target price of $4

Lucid Diagnostics Share Price Target

Get share price movements and forecasts by analysts on Lucid Diagnostics.

What analysts predicted

89.56%UPSIDE

Target Price

$4

Current Price

$0.4175

Analyzed by

3 Analysts

High

$3

Target

$4.00

Low

$2.5

Lucid Diagnostics target price $4, a slight upside of 89.56% compared to current price of $0.4175. According to 3 analysts rating.

Indian Investors' Interest in Lucid Diagnostics Stock

Search interest for Lucid Diagnostics Stock has increased by 290% in the last 30 days, reflecting an upward trend in search activity.

Time period: to

Change:290% versus previous 30 day period

Lucid Diagnostics Quarterly Profit & Loss

All numbers in Millions USD

Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Total Revenue
1
0
1
1
0
1
1
1
1
1
Gross Profit
0
0
0
0
0
0
0
0
0
0
Operating Income
-10
-11
-11
-12
-12
-11
-11
-14
-12
-12
EBITDA
-10
-10
-12
-11
-26
-4
-10
-16
-13
-11
Interest Expense
0
0
0
0
0
0
0
0
0
0
Depreciation
0
0
0
0
0
0
0
0
0
0
Income Before Tax
-10
-11
-12
-11
-26
-4
-10
-16
-13
-11
Income Tax Expense
-
-
-
-
-
-
-
-
-
-
Net Income
-10
-11
-12
-11
-26
-4
-10
-16
-13
-11
Net Profit Margin
-65.43%
-65.37%
-43.69%
-79.20%
-87.32%
-53.48%
-40.13%
-23.67%
-47.05%
1.97%

Lucid Diagnostics Annual Profit & Loss

All numbers in Millions USD

Dec 2018
Dec 2019
Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Dec 2025
Total Revenue
-
-
-
0
0
2
4
4
Gross Profit
-
-
-
0
-3
-6
-3
-2
Operating Income
-1
-4
-8
-27
-56
-48
-46
-49
EBITDA
0
0
0
-27
-54
-49
-44
-57
Interest Expense
-
-
-
0
0
0
0
0
Depreciation
1
4
8
0
1
2
1
0
Income Before Tax
-1
-4
-8
-28
-56
-52
-45
-58
Income Tax Expense
-
-
-
-
-
-
-
-
Net Income
-1
-4
-8
-28
-56
-52
-45
-58
Net Profit Margin
0.00%
0.00%
0.00%
-17.00%
-858.62%
-249.18%
-90.20%
-60.26%

Lucid Diagnostics Quarterly Cash Flow

All numbers in Millions USD

Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Net Income
-10
-11
-12
-11
-26
-4
-10
-26,652
-13
-11
Operating Cash Flow
-12
-11
-10
-9
-12
-10
-10
-12
-12
-11
Investing Cash Flow
0
-
0
0
0
0
0
0
0
0
Financing Cash Flow
18
11
0
17
15
16
27
0
5
16
Change in Cash
5
0
-10
7
2
5
16
-12
-6
5

Lucid Diagnostics Annual Cash Flow

All numbers in Millions USD

Dec 2018
Dec 2019
Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Dec 2025
Net Income
-1
-4
-8
-28
-56
-52
-45
-58
Operating Cash Flow
0
-2
-5
-17
-29
-32
-44
-46
Investing Cash Flow
-
-
-
0
-4
0
0
0
Financing Cash Flow
0
2
5
72
2
29
48
59
Change in Cash
0
0
0
53
-31
-3
3
12

Global Institutional Holdings in Lucid Diagnostics

Check out the Institutions with significant holdings in Lucid Diagnostics.

Funds
Holdings
BlackRock, Inc.
4.12%
Vanguard
3.43%
VANGUARD INDEX FUNDS
3.15%
iShares
2.70%
Lishan Aklog
1.79%
See all

Lucid Diagnostics News & Key Events

  • img

    Today's Timeline - 22 October

    Fri, 02:29 AM

    -

    Lucid Diagnostics raised $15M through Series C Preferred Stock and resolved Medicare payment concerns, stabilizing its capital structure.

Insights on Lucid Diagnostics

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgPOSITIVE IMPACT

    Profit Spike

    img

    Netprofit is up for the last 3 quarters, -16.26M → -11.68M (in $), with an average increase of 18.0% per quarter

  • imgPOSITIVE IMPACT

    Revenue Rich

    img

    Revenue is up for the last 2 quarters, 1.25M → 1.47M (in $), with an average increase of 14.8% per quarter

  • imgNO EFFECT

    Against Peers

    img

    In the last 3 years, Edwards Lifesciences Corp has given 63.1% return, outperforming this stock by 127.1%

  • imgNO EFFECT

    Against Peers

    img

    In the last 1 year, Edwards Lifesciences Corp has given 24.5% return, outperforming this stock by 84.7%

  • imgNEGATIVE IMPACT

    Price Dip

    img

    In the last 1 month, LUCD stock has moved down by -34.6%

About Lucid Diagnostics

Lucid Diagnostics Inc. is a commercial-stage medical technology firm focused on diagnostic solutions. The company's primary objective is to serve patients afflicted with gastroesophageal reflux disease (GERD), commonly referred to as chronic heartburn or acid reflux, especially those at increased risk of developing precancerous esophageal conditions or the particularly aggressive esophageal adenocarcinoma. Their key product offerings include EsoGuard, an internally developed esophageal DNA test, and EsoCheck, a specialized device designed for collecting esophageal cells. Formed in 2018, Lucid Diagnostics Inc. has its headquarters in New York, New York, and operates as a subsidiary of PAVmed Inc.
OrganisationLucid Diagnostics
Headquarters360 Madison Avenue, New York City, NY, 10017, US
IndustryMedical - Devices
CEOLishan Aklog

Key Management of Lucid Diagnostics

Name

Title

Mr. Michael Adam Gordon

General Counsel & Secretary

Dr. Joseph Willis M.D.

Co-founder & Strategic Advisor

Dr. Suman M. Verma M.D., Ph.D.

Senior VP & Chief Scientific Officer

Dr. Amitabh Chak M.D.

Co-Founder & Strategic Advisor

Helen Moinova Ph.D.

Co-Founder & Strategic Advisor

Dr. Brian J. deGuzman M.D.

Chief Technology & Compliance Officer

Dr. Lishan Aklog M.D.

Chairman & CEO

Mr. Shaun M. O'Neill M.B.A.

President & COO

Mr. Dennis M. McGrath CPA

Chief Financial Officer

Dr. Sanford D. Markowitz M.D., Ph.D.

Co-Founder & Strategic Advisor

FAQs

What is Lucid Diagnostics share price today?

Lucid Diagnostics share price today is $0.42 as on at the close of the market. Lucid Diagnostics share today touched a day high of $0.43 and a low of $0.40.

What is the 52 week high and 52 week low for Lucid Diagnostics share?

Lucid Diagnostics share touched a 52 week high of $1.63 on and a 52 week low of $0.30 on . Lucid Diagnostics stock price today i.e. is closed at $0.42,which is 74.38% down from its 52 week high and 37.79% up from its 52 week low.

What is Lucid Diagnostics's market capitalisation today?

Lucid Diagnostics market capitalisation is $0.00T as on .

How to invest in Lucid Diagnostics Stock (LUCD) from India?

  1. Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
  2. Step 2: Search for Lucid Diagnostics on INDmoney app. Click on Buy button.

What is the minimum amount required to buy Lucid Diagnostics Stock (LUCD) from India?

Indian investors can start investing in Lucid Diagnostics (LUCD) shares with as little as ₹93.92749786376953 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹939.27 in Lucid Diagnostics stock (as per the Rupee-Dollar exchange rate as on ). Based on Lucid Diagnostics share’s latest price of $0.42 as on November 10, 2026 at 8:46 am IST, you will get 23.9521 shares of Lucid Diagnostics. Learn more about fractional shares .

What are the returns that Lucid Diagnostics has given to Indian investors in the last 5 years?

Lucid Diagnostics stock has given -95.63% share price returns and 26.61% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?